Terry Treadwell, MD, FACS
Medical Director
Institute for Advanced Wound Care
Montgomery, Alabama

After completing this activity, participants should be able to:

• Define the physiological and biochemical disorders that cause venous leg ulcers
• Explain the science behind compression therapy and compression bandages for venous leg ulcers and the swollen limb
• Compare and contrast the various compression bandage modalities for managing venous leg ulcers
• Apply contemporary evidence-based treatment strategies for venous leg ulcers based on individual patient needs

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested for video programs (please download here). A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

North American Center for Continuing Medical Education, LLC (NACCME) is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine.

This program is approved for 1 continuing education contact hour or 0.1 CEU.

Physical Therapists: North American Center for Continuing Medical Education, LLC (NACCME) has applied for preapproved accreditation in only the states that require preapproval: Arizona, Florida, Louisiana, and Texas. If you practice in any other state, simply forward a copy of your Certificate of Completion to the PT Board in your area.

Independent Clinical Reviewer: David J. Margolis, MD, PhD, Associate Professor, Dept. of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania

Nurse Reviewer: Edna Atwater, RN, BSN, Past-President, Dermatology Nurses’ Association, Dermatology Nursing Institute Founding Board Member, Administrative Director, Wound Management Institute, Health Center Administrator, Dermatology, Duke University Medical Center, Durham, North Carolina

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity.  All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest.  If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
                 
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Treadwell: Grant/Research Support—Celgene, HealthPoint, Organogenesis Inc., Sorbion AG; Consultant—Celgene; Promotional Speakers’ Bureau—Organogenesis Inc., Systagenix
Dr. Macdonald: Scientific Advisor—3M; Promotional Speakers’ Bureau—3M
Ms. Atwater: Disclosed no relevant financial relationships with any commercial interests
Dr. Margolis: Scientific Advisor—CoDa, Intercytex, Organogenesis, Pfizer, Wound Solutions Ltd.

Mr. Kearney, Ms. Kruggel, Ms. McCardell, Ms. Oliver, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations. 

The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed